Royalty Pharma

Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation in the life sciences industry. The firm's business model involves acquiring royalty streams from existing therapies and providing upfront capital to biopharmaceutical companies, academic institutions, and research organizations in exchange for future royalty payments. This includes co-funding late-stage clinical trials and new product launches. The company maintains a diversified portfolio of royalties on many of the industry's leading therapies.